Dopamine Agonists and MAO‑B Inhibitors for Parkinson’s Disease
1. Introduction/Overview Parkinson’s disease (PD) is a progressive neurodegenerative disorder primarily characterized by the loss of dopaminergic neurons within the substantia nigra…
Topic Archive
Category: Uncategorized
Chapter: Atypical Antipsychotics
Introduction / Overview Atypical antipsychotics, also referred to as second‑generation antipsychotics, have become foundational agents in the management of schizophrenia, bipolar disorder,…
Tricyclic Antidepressants: Pharmacology and Clinical Applications
Introduction and Overview Tricyclic antidepressants (TCAs) represent a foundational class of antidepressant agents that were introduced in the 1950s and have since…
Selective Serotonin Reuptake Inhibitors (SSRIs)
Introduction/Overview Selective serotonin reuptake inhibitors (SSRIs) constitute a pivotal class of antidepressant agents that have reshaped the therapeutic landscape of mood and…
SNRIs and MAO Inhibitors: Pharmacology, Clinical Uses, and Patient Management
1. Introduction/Overview Serotonin‑norepinephrine reuptake inhibitors (SNRIs) and monoamine oxidase inhibitors (MAOIs) comprise two distinct families of antidepressants that have evolved into critical…
Mood Stabilizers (Lithium)
Introduction Lithium has long been regarded as a cornerstone in the management of bipolar disorder, offering both acute and long‑term therapeutic benefits.…
Opioid Agonists (Morphine, Codeine)
Introduction/Overview Opioid agonists constitute a foundational class of analgesics employed worldwide for the management of moderate to severe pain. Among these, morphine…
Synthetic Opioids: Fentanyl and Methadone
Introduction/Overview Synthetic opioids are chemically engineered analogs of naturally occurring opiates. Fentanyl and methadone represent two pivotal agents within this class, each…
Opioid Antagonists and Partial Agonists
Introduction/Overview Brief Introduction to the Topic Opioid pharmacotherapy has evolved considerably over the past several decades, with a growing emphasis on agents…
CNS Stimulants: Amphetamines and Methylphenidate
Introduction/Overview Central nervous system (CNS) stimulants constitute a pivotal class of pharmacotherapeutic agents employed in the management of attention-deficit/hyperactivity disorder (ADHD), narcolepsy,…